Potential role of 4-1BB in T cell activation. Comparison with the costimulatory molecule CD28
- PMID: 7561030
Potential role of 4-1BB in T cell activation. Comparison with the costimulatory molecule CD28
Abstract
The expression of the murine T cell Ag 4-1BB, a member of the TNF-R family, is induced by T cell activation. Previously, we and others had shown that signaling through 4-1BB enhanced proliferative T cell responses. To investigate a potential role for the interaction of 4-1BB with its ligand (4-1BBL) in T cell activation, we studied the ability of a soluble chimera of 4-1BB (4-1BBFc) to interfere with proliferative responses and cytokine production in models of activation dependent in intercellular interactions. The potential blocking effect of 4-1BBFc was compared with that of the chimeric molecule CTLA-4Ig, a reagent known to interfere with the interaction of CD28 (and/or CTLA-4) with B7 costimulatory receptors. In this study, we report that 4-1BBFc partially blocked both the activation of unfractionated splenocytes triggered by soluble anti-CD3 (anti-CD3s), and the more physiologically relevant responses to alloantigen. In addition, we show that both chimeric molecules partially blocked proliferative responses and IL-2 secretion by highly purified resting T cells activated with anti-CD3s in the presence of fixed accessory cells that express B7 receptors and 4-1BBL. Furthermore, in this model system, the blocking capacity of 4-1BBFc and CTLA-4Ig appears to correlate with the relative expression of their respective cognate receptors (4-1BBL and B7) on the accessory cell. Simultaneous addition of both blocking reagents produced an additive effect in the model systems studied.
Similar articles
-
Signals through 4-1BB are costimulatory to previously activated splenic T cells and inhibit activation-induced cell death.J Immunol. 1997 Mar 15;158(6):2600-9. J Immunol. 1997. PMID: 9058792
-
Differential expression and costimulatory effect of 4-1BB (CD137) and CD28 molecules on cytokine-induced murine CD8(+) Tc1 and Tc2 cells.Cell Immunol. 1999 Feb 25;192(1):63-71. doi: 10.1006/cimm.1998.1433. Cell Immunol. 1999. PMID: 10066348
-
Polarization effects of 4-1BB during CD28 costimulation in generating tumor-reactive T cells for cancer immunotherapy.Cancer Res. 2003 May 15;63(10):2546-52. Cancer Res. 2003. PMID: 12750278
-
Role of 4-1BB:4-1BB ligand in cancer immunotherapy.Cancer Gene Ther. 2004 Mar;11(3):215-26. doi: 10.1038/sj.cgt.7700670. Cancer Gene Ther. 2004. PMID: 14671675 Review.
-
Role of 4-1BB in immune responses.Semin Immunol. 1998 Dec;10(6):481-9. doi: 10.1006/smim.1998.0157. Semin Immunol. 1998. PMID: 9826581 Review.
Cited by
-
Fcγ receptors and immunomodulatory antibodies in cancer.Nat Rev Cancer. 2024 Jan;24(1):51-71. doi: 10.1038/s41568-023-00637-8. Epub 2023 Dec 7. Nat Rev Cancer. 2024. PMID: 38062252 Review.
-
The emerging landscape of novel 4-1BB (CD137) agonistic drugs for cancer immunotherapy.MAbs. 2023 Jan-Dec;15(1):2167189. doi: 10.1080/19420862.2023.2167189. MAbs. 2023. PMID: 36727218 Free PMC article. Review.
-
Invariant natural killer T cells regulate anti-tumor immunity by controlling the population of dendritic cells in tumor and draining lymph nodes.J Immunother Cancer. 2014 Oct 14;2(1):37. doi: 10.1186/s40425-014-0037-x. eCollection 2014. J Immunother Cancer. 2014. PMID: 25349699 Free PMC article.
-
N-Glycosylation Facilitates 4-1BB Membrane Localization by Avoiding Its Multimerization.Cells. 2022 Jan 4;11(1):162. doi: 10.3390/cells11010162. Cells. 2022. PMID: 35011724 Free PMC article.
-
Early loss of T lymphocyte 4-1BB receptor expression is associated with higher short-term mortality in alcoholic hepatitis.PLoS One. 2021 Aug 5;16(8):e0255574. doi: 10.1371/journal.pone.0255574. eCollection 2021. PLoS One. 2021. PMID: 34352016 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Research Materials